Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← David Einhorn, latest 13F

Talis Biomedical

In David Einhorn's portfolio · Greenlight Capital

Ticker TLIS

Not in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2024 Sell 0  
Q2 2024 No change 149,052 0.1% $8.66 $1.3M
Q1 2024 No change 149,052 0.1% $8.75 $1.3M
Q4 2023 No change 149,052 0.1% $7.45 $1.1M
Q3 2023 No changeafter split 149,052 0.0% $5.77 $860K
Q2 2023 No change 2,235,783 0.1% $0.48 $1.1M
Q1 2023 No change 2,235,783 0.1% $0.49 $1.1M
Q4 2022 No change 2,235,783 0.1% $0.45 $996K
Q3 2022 No change 2,235,783 0.1% $0.68 $1.5M
Q2 2022 No change 2,235,783 0.1% $0.81 $1.8M
Q1 2022 Add 42% 2,235,783 0.2% $1.41 $3.2M
Q4 2021 Buy 1,569,300 0.4% $4.01 $6.3M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.